Abstract:Osteoarthritis (OA) is the second-commonest arthritis, but pathogenic and regulatory mechanisms underlying OA remain incompletely understood. Here, we aimed to identify the mechanisms associated with microRNA-1 (miR-1) treatment of OA in rodent OA models using a proteomic approach. First, N = 18 Sprague Dawley (SD) rats underwent sham surgery ( n = 6) or ACL transection ( n = 12), followed at an interval of one week by randomization of the ACL transection group to intra-articular administration of either 50 μL placebo (control group) or miR-1 agomir, a mimic of endogenous miR-1 (experimental group). After allowing for eight weeks of remodeling, articular cartilage tissue was harvested and immunohistochemically stained for the presence of MMP-13. Second, N = 30 Col2a1-cre-ERT2 /GFPf1/fl -RFP-miR-1 transgenic mice were randomized to intra-articular administration of either placebo (control group, N = 15) or tamoxifen, an inducer of miR-1 expression (experimental group, N = 15), before undergoing surgical disruption of the medial meniscus (DMM) after an interval of five days. After allowing for eight weeks of remodeling, articular cartilage tissue was harvested and underwent differential proteomic analysis. Specifically, tandem mass tagging (TMT) quantitative proteomic analysis was employed to identify inter-group differentially-expressed proteins (DEP), and selected DEPs were validated using real-time quantitative polymerase chain reaction (RT-qPCR) technology. Immunohistochemically-detected MMP-13 expression was significantly lower in the experimental rat group, and proteomic analyses of mouse tissue homogenate demonstrated that of 3526 identified proteins, 345 were differentially expressed (relative up- and down-regulation) in the experimental group. Proteins Fn1, P4ha1, P4ha2, Acan, F2, Col3a1, Fga, Rps29, Rpl34, and Fgg were the *top ten most-connected proteins, implying that miR-1 may regulate an expression network involving these proteins. Of these ten proteins, three were selected for further validation by RT-qPCR: the transcript of Fn1, known to be associated with OA, exhibited relative upregulation in the experimental group, whereas the transcripts of P4ha1 and Acan exhibited relative downregulation. These proteins may thus represent key miR-1 targets during OA-regulatory mechanisms, and may provide additional insights regarding therapeutic mechanisms of miR-1 in context of OA.

MicroRNA-218-5p As a Potential Target for the Treatment of Human Osteoarthritis.

MicroRNA-16-5p Controls Development of Osteoarthritis by Targeting SMAD3 in Chondrocytes.

MicroRNA‑186‑5p Downregulation Inhibits Osteoarthritis Development by Targeting MAPK1.

Silencing miR-146a-5p Protects against Injury-Induced Osteoarthritis in Mice

MiR-203a-3p attenuates apoptosis and pyroptosis of chondrocytes by regulating the MYD88/NF-κB pathway to alleviate osteoarthritis progression

Overexpression of Microrna-634 Suppresses Survival and Matrix Synthesis of Human Osteoarthritis Chondrocytes by Targeting Pik3r1

MicroRNA-410-3p modulates chondrocyte apoptosis and inflammation by targeting high mobility group box 1 (HMGB1) in an osteoarthritis mouse model

Mir-146B Accelerates Osteoarthritis Progression by Targeting Alpha-2-macroglobulin

Downregulated Microrna‐106 Inhibits Apoptosis and Promotes Proliferation and Differentiation of Chondrocytes in Osteoarthritis Through Restraining the Activation of Wnt/β‐catenin Pathway

MicroRNA-455-3p Promotes TGF-β Signaling and Inhibits Osteoarthritis Development by Directly Targeting PAK2.

Microrna-34a Affects Chondrocyte Apoptosis And Proliferation By Targeting The Sirt1/P53 Signaling Pathway During The Pathogenesis Of Osteoarthritis

MicroRNA-140-5p represses chondrocyte pyroptosis and relieves cartilage injury in osteoarthritis by inhibiting cathepsin B/Nod-like receptor protein 3

Intra-articular Delivery of Antago-miR-483-5p Inhibits Osteoarthritis by Modulating Matrilin 3 and Tissue Inhibitor of Metalloproteinase 2.

MicroRNA-320c Inhibits Development of Osteoarthritis Through Downregulation of Canonical Wnt Signaling Pathway

TMT quantitative proteomics reveals key proteins relevant to microRNA-1-mediated regulation in osteoarthritis

miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence

MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β

Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis

Mir-93-5p Attenuates IL-1β-induced Chondrocyte Apoptosis and Cartilage Degradation in Osteoarthritis Partially by Targeting TCF4

Mir-146A Facilitates Osteoarthritis by Regulating Cartilage Homeostasis Via Targeting Camk2d and Ppp3r2.

MicroRNA-197 Regulates Chondrocyte Proliferation, Migration, and Inflammation in Pathogenesis of Osteoarthritis by Targeting EIF4G2.